Clinical Trial Detail

NCT ID NCT00254319
Title Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Cooper Health System
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Bevacizumab + Pemetrexed Disodium

Age Groups: adult

No variant requirements are available.